Are we underestimating seroprevalence of SARS-CoV-2?

BMJ. 2020 Sep 3:370:m3364. doi: 10.1136/bmj.m3364.

Authors

Stephen Burgess¹, Mark J Ponsford², Dipender Gill³

Affiliations

¹ MRC Biostatistics Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK sb452@medschl.cam.ac.uk.
² Immunodeficiency Centre of Wales, University Hospital Wales, Cardiff, UK.
³ Clinical Pharmacology and Therapeutics Section, Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St George's, University of London, London, UK.

No abstract available

Publication types

Editorial

MeSH terms

Betacoronavirus*
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques*
Coronavirus Infections / diagnosis*
Coronavirus Infections / epidemiology*
Humans
Pandemics
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / epidemiology*
SARS-CoV-2
Seroepidemiologic Studies

Grants and funding